Publication date February 19, 2026. This report provides a regulatory style update on a trial that investigates offset analgesia linked to cold temperature and offset analgesia linked to heat. The two interventions under study are described as strategies to modulate pain perception and are conducted under the sponsorship of Aalborg University. The registered trial on ClinicalTrials.gov is NCT07395869 and the status is not yet recruiting. This information helps device developers, regulators, and researchers evaluate safety and performance considerations for devices that use temperature to influence pain signals.
What is offset analgesia and what does this trial examine?
Offset analgesia describes a measurable drop in pain following a small change in thermal input. It is used in temperature based contexts to understand how modest adjustments in heat or cold influence pain perception. The trial tests whether cold induced offset analgesia and heat induced offset analgesia can be produced through a device based approach. The goal is to determine how predictable these responses are and what safety features would be required for clinical or consumer use. By examining both cold and heat variants, the study seeks to inform potential device configurations that aim to deliver targeted analgesia while preserving tissue safety.
Definition and hypothesis
The concept rests on a brief temperature change that yields a larger reduction in perceived pain than would be expected from the change alone. The hypothesis is that cold offset analgesia and heat offset analgesia could be reproducible using controlled device inputs, enabling targeted analgesia with mindful limits on tissue stress.
Interventions and endpoints
The record lists two interventions described as offset analgesia strategies: heat based offset analgesia and cold based offset analgesia. The exact endpoints are not detailed in the public record, but the study is described as evaluating safety and performance relevant to temperature based analgesia devices. The information suggests a focus on how device controlled temperature changes may influence pain signals in a repeatable manner.
How is the trial structured and who is sponsoring?
The sponsor is Aalborg University. The record indicates the study is not yet recruiting and is registered on ClinicalTrials.gov as NCT07395869. The design appears to involve two experimental arms focused on temperature driven offset analgesia, with emphasis on safety, feasibility, and signal clarity for potential device based applications. The trial status signals an early stage where protocol details are typically refined prior to enrollment, and final data will inform future regulatory considerations and device development plans.
For device developers, this implies attention to calibration procedures, user training, and clear risk management documentation. Regulators will expect a robust plan for monitoring adverse events and ensuring that any device claims align with demonstrated safety profiles once results are available.
What are the regulatory implications for devices?
Regulators review temperature based pain modulation devices for safety and performance claims. This trial signals a focus on offset analgesia related to cold and heat, which could affect how future devices are positioned in terms of intended use and claimed benefits. The MDR requires a documented intended purpose, evidence of performance, and comprehensive risk management. Sponsors and manufacturers should monitor updates to align pre market submissions with announced study plans and any published data. Until results are published, this update remains a preliminary signal guiding future regulatory conversations about device design and testing requirements.
In practice, a device’s regulatory path would likely include defined performance endpoints, demonstration of temperature control accuracy, and a clear framework for thermal safety. Stakeholders should consider how such endpoints fit with existing guidance and how anticipated data might influence labeling, post market surveillance, and risk mitigation measures.
What about safety and ethics?
Safety considerations include thermal safety limits, patient monitoring, and device built in failure protections. Ethical oversight and informed consent are standard for trials of temperature based pain modulation. Until results are published, the safety profile remains an area of ongoing evaluation by the sponsor and the regulatory community. Practitioners should monitor for any protocol amendments, adverse event reporting, or changes in recruitment status that could impact the interpretation of later findings.
Where can I read more?
External link to the ClinicalTrials.gov record is provided for readers seeking the official trial details. ClinicalTrials.gov record NCT07395869.
For related discussions see Offset analgesia insights and Clinical trials regulation updates.
FAQ
- 1. What is offset analgesia A phenomenon where small changes in temperature can influence subsequent pain perception, studied in this context as a potential device based approach.
- 2. Who is sponsoring Aalborg University is listed as the sponsor on the ClinicalTrials.gov record.
- 3. Where can I read the official record The trial is registered under NCT07395869 on ClinicalTrials.gov and is not yet recruiting.
Conclusion
This update highlights a trial exploring cold and heat offset analgesia under a device oriented framework. Until results are published, readers should treat all claims as preliminary. Regulators, developers, and researchers should monitor for new data that could influence device design and regulatory submissions.
Disclaimer
This information is intended for professionals. It is not legal advice and does not replace regulatory counsel.
https://clinicaltrials.gov/study/NCT07395869?term=medical+device